The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis:: prospective post-marketing study in progress

被引：0
|
作者：
Zozulya, N. I. . [1 ]
Plyushch, O. P. [1 ]
Severova, T. V. [1 ]
机构：
[1] Moscow Hemophilia Ctr, Moscow, Russia
来源：
HAEMOPHILIA | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [31] Immune tolerance induction with human-cl rhFVIII in patients with severe haemophilia A and inhibitors
    Hall, G.
    Bhatnagar, N.
    Khair, K.
    Wilkinson, A.
    Belyanskaya, L.
    Liesner, R.
    HAEMOPHILIA, 2019, 25 : 93 - 93
  • [32] Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance database
    Garon-Czmil, Julie
    Petitpain, Nadine
    Rouby, Franck
    Sassier, Marion
    Babai, Samy
    Yelehe-Okouma, Melissa
    Weryha, Georges
    Klein, Marc
    Gillet, Pierre
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (02) : 241 - 249
  • [33] Treatment of Haemophilia a (HA) Patients with Inhibitors: Immune Tolerance Induction with a Single Factor VIII/Von Willebrand Factor Concentrate in an Observational Immune Tolerance Induction Study (ObsITI)
    Ettingshausen, C. Escuriola
    Berntorp, Erik
    Dargaud, Yesim
    Gutowski, Zeynep
    Negrier, Claude
    Pavlova, Anna
    Oldenburg, Johannes
    BLOOD, 2018, 132
  • [34] Immune Tolerance Induction with Simoctocog Alfa (Nuwiq®) in Six Patients with Severe Haemophilia a and FVIII Inhibitors
    Bhatnagar, Neha
    Khair, Kate
    Liesner, Ri
    Wilkinson, Alice
    Belyanskaya, Larisa
    BLOOD, 2018, 132
  • [35] Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product
    Rangarajan, S.
    Jimenez-Yuste, V.
    Santagostino, E.
    HAEMOPHILIA, 2014, 20 (06) : E414 - E417
  • [36] Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors
    Unuvar, A.
    Kavakli, K.
    Baytan, B.
    Kazanci, E.
    Sayli, T.
    Oren, H.
    Celkan, T.
    Gursel, T.
    HAEMOPHILIA, 2008, 14 (02) : 315 - 322
  • [37] Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study
    Rivard, G. E.
    Rothschild, C.
    Toll, T.
    Achilles, K.
    HAEMOPHILIA, 2013, 19 (03) : 449 - 455
  • [38] Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response
    Gringeri, A.
    Musso, R.
    Mazzucconi, M. G.
    Piseddu, G.
    Schiavoni, M.
    Pignoloni, P.
    Mannucci, P. M.
    HAEMOPHILIA, 2007, 13 (04) : 373 - 379
  • [39] Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII
    Carpenter, S. L.
    Khair, K.
    Gringeri, A.
    Valentino, L. A.
    HAEMOPHILIA, 2018, 24 (04) : 570 - 577
  • [40] Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis
    Odeyemi, Isaac A. O.
    Dano, Anne M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 239 - 250
12345